Search results for "inflammation"

showing 10 items of 2662 documents

The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardio…

2013

Background: We assessed the influence of atorvastatin on selected indicators of an inflammatory condition, left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy (DCM). Methods. We included 68 DCM patients with left ventricular ejection fraction (LVEF) ≤40% treated optimally in a prospective, randomized study. They were observed for 5 years. Patients were divided into two groups: patients who were commenced on atorvastatin 40 mg daily for two months followed by an individually matched dose of 10 or 20 mg/day (group A), and patients who were treated according to current recommendations without statin therapy (group B). Results: After 5-year follow-u…

Cardiomyopathy DilatedMalemedicine.medical_specialtyStatinmedicine.drug_classAtorvastatinEndocrinology Diabetes and MetabolismClinical BiochemistryDiastoleCardiomyopathyDilated cardiomyopathyHemodynamicsHeart failureAtorvastatin Dilated cardiomyopathy Heart failure InflammationVentricular Function LeftEndocrinologyInternal medicinemedicineAtorvastatinHumansPyrrolescardiovascular diseasesAgedBiochemistry medicalInflammationEjection fractionbusiness.industryResearchBiochemistry (medical)Anti-Inflammatory Agents Non-SteroidalDilated cardiomyopathyMiddle Agedmedicine.diseaseUric AcidHospitalizationHeptanoic AcidsHeart failureCardiologyCytokinesFemalebusinessmedicine.drugFollow-Up StudiesLipids in health and disease
researchProduct

May the force be with you: Transfer of healthy mitochondria from stem cells to stroke cells

2018

Stroke is a major cause of death and disability in the United States and around the world with limited therapeutic option. Here, we discuss the critical role of mitochondria in stem cell-mediated rescue of stroke brain by highlighting the concept that deleting the mitochondria from stem cells abolishes the cells’ regenerative potency. The application of innovative approaches entailing generation of mitochondria-voided stem cells as well as pharmacological inhibition of mitochondrial function may elucidate the mechanism underlying transfer of healthy mitochondria to ischemic cells, thereby providing key insights in the pathology and treatment of stroke and other brain disorders plagued with…

Cardiorespiratory Medicine and HaematologyMitochondrionRegenerative medicineRats Sprague-Dawley0302 clinical medicineStem Cell Research - Nonembryonic - Humanenergy metabolismStrokeStem CellsBrainCerebral ischemiaMitochondriaStrokeNeurologycellular bioenergeticStem Cell Research - Nonembryonic - Non-HumanStem cellmedicine.symptomCardiology and Cardiovascular Medicine1.1 Normal biological development and functioningClinical SciencesEnergy metabolismregenerative medicineInflammation03 medical and health sciencesUnderpinning researchmedicineAnimalsHumansNeurology & NeurosurgeryAnimalbusiness.industryMechanism (biology)NeurosciencesStem Cell Researchmedicine.diseaseRatsBrain DisordersTransplantationDisease Models AnimalinflammationDisease ModelsCommentarycellular bioenergeticsSprague-DawleyNeurology (clinical)businessNeuroscience030217 neurology & neurosurgerytransplantationJournal of Cerebral Blood Flow & Metabolism
researchProduct

Current and emerging drugs for the treatment of atherosclerosis: the evidence to date

2022

Introduction: Atherosclerosis can be considered a chronic inflammatory process that stands out as a dominant cause of cardiovascular disease (CVD). Since blood lipids are the leading risk factor for atherosclerosis development, lowering low-density lipoprotein cholesterol (LDL-C) and other apolipoprotein B-containing lipoproteins reduces the risk of future cardiovascular events. However, there has been significant progress in developing lipid-lowering drugs for aggressive management of dyslipidemia, the rates of CVD events remain unacceptably high, so there is great need to identify novel therapeutic pathways targeting the atherosclerosis process.Areas covered: We discussed the current guid…

Cardiovascular DiseasesInternal MedicineHumansCholesterol LDLAtherosclerosis cardiovascular disease inflammation oxidative stress preventionGeneral MedicineAtherosclerosisOxidantsCardiology and Cardiovascular MedicineLipidsDyslipidemiasExpert Review of Cardiovascular Therapy
researchProduct

Atrial natriuretic factor, but not oxytocin, is present in atherosclerotic plaques of human common carotid arteries

2010

We performed a study on 25 common carotid arteries (CCA) affected by atherosclerotic plaques, comparing them to 25 normal CCA. We researched the presence and localisation of atrial natriuretic factor (ANF) and oxytocin (OX) by immunohistochemistry. We found ANF abundantly expressed in plaques, mainly localising in intima and subintima layers; by contrast normal vessels were scarcely positive or negative; finally, OX resulted negative or weakly positive in both atherosclerotic and normal vessels. Our results show for the first time ANF presence in atherosclerotic plaques of CCA and are in agreement with other studies, mainly performed in vitro, that hypothesise the involvement of this molecu…

Carotid Artery DiseasesMaleNatriuretic peptide Atherosclerosis InflammationSettore BIO/16 - Anatomia UmanaAnti-Inflammatory AgentsMiddle AgedOxytocinImmunohistochemistryDrug DesignHumansCarotid StenosisFemaleTunica IntimaVasculitis Central Nervous SystemAtrial Natriuretic FactorBiomarkersAged
researchProduct

Markers of Inflammation and Infection Influence the Outcome of Patients With Baseline Asymptomatic Carotid Lesions

2005

Background and Purpose— It is still in debate whether the evaluation of markers of infection and inflammation may be of importance for cerebrovascular and cardiovascular prevention, and we aimed to investigate this field in a prospective 5-year clinical follow-up study in patients with early stages of atherosclerosis. Methods— We studied 668 subjects divided in 3 groups according to the results of carotid ultrasound examination: (1) normal subjects, if intima-media thickness (IMT) was <0.9 mm; (2) with IMT, if IMT was between 0.9 and 1.5 mm; and (3) with asymptomatic carotid plaque, if IMT was >1.5 mm. Traditional cardiovascular risk factors were investigated, and laboratory analysis…

Carotid Artery DiseasesMalePathologyTime FactorsCytomegalovirusFibrinogenCardiovascular SystematherosclerosiRisk FactorsStrokeUltrasonographyChlamydiabiologyChlamydophila pneumoniaeMiddle AgedLipidsEchocardiography DopplerStrokeC-Reactive ProteinCarotid ArteriesCardiovascular DiseasesDisease ProgressionFemalemedicine.symptomTunica MediaCardiology and Cardiovascular Medicinemedicine.drugmedicine.medical_specialtyCongenital cytomegalovirus infectionInfectionsAsymptomaticCentral nervous system diseaseSex FactorsInternal medicinemedicineHumanscarotid arterieAgedAdvanced and Specialized NursingAnalysis of VarianceHelicobacter pyloriVascular diseasebusiness.industryFibrinogenHelicobacter pyloriAtherosclerosisbiology.organism_classificationmedicine.diseaseinfectioninflammationImmunoglobulin GNeurology (clinical)Tunica IntimabusinessFollow-Up StudiesStroke
researchProduct

Inflammation, atherosclerotic burden and cardiovascular prognosis.

2006

The aim of this study was to evaluate the impact of various inflammatory markers on atherosclerotic burden and cardiovascular prognosis.In a prospective study 720 patients preceding coronary angiography were enrolled. In all patients carotid and leg arteries were examined using sonographic methods and C-reactive protein, fibrinogen, interleukin-18 (IL-18) and interleukin-6 have been determined. Patients were compared with regard to atherosclerotic burden: no clinically significant stenosis (N=57, 7.9%), coronary artery disease only (N=362, 50.3%), coronary artery disease with peripheral atherosclerosis (=multi-vascular atherosclerosis, N=301, 41.8%).Follow-up data after a median of 6.5 year…

Carotid Artery DiseasesMalemedicine.medical_specialtyInflammationCoronary Artery DiseaseFibrinogenCoronary AngiographyCoronary artery diseasePredictive Value of TestsInternal medicineGermanymedicineLaser-Doppler FlowmetryHumansProspective StudiesProspective cohort studyAgedUltrasonographyInflammationPeripheral Vascular Diseasesbusiness.industryHazard ratioInterleukin-18FibrinogenMiddle Agedmedicine.diseasePrognosisConfidence intervalFemoral ArteryStenosisPredictive value of testsCardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessBiomarkersmedicine.drugFollow-Up StudiesAtherosclerosis
researchProduct

Altered expression of inflammation-related genes in human carotid atherosclerotic plaques.

2011

Abstract Objective Inflammation is a pivotal process in atherosclerosis development and progression, but the underlying molecular mechanisms remain largely obscure. We have conducted an extensive expression study of atherosclerotic plaques to identify the inflammatory pathways involved in atherosclerosis. Methods We studied 11 human carotid plaques, their respective adjacent regions and 7 control arteries from different subjects. Expression of 92 genes was studied by TaqMan low-density array human inflammation panel. Human aortic endothelial and smooth muscle cells were used for in vitro experiments. Results The mRNA levels of 44/92 genes (48%) differed significantly between the tissues exa…

Carotid Artery DiseasesMalemedicine.medical_specialtyMyocytes Smooth MuscleReceptors ProstaglandinPTGS1InflammationReceptors EpoprostenolSettore MED/22 - Chirurgia VascolareMuscle Smooth VascularCytochrome P-450 Enzyme SystemInternal medicineGene expressionmedicineHumansRNA MessengerReceptors CytokineCells CulturedAgedRegulation of gene expressionInflammationbiologyTumor Necrosis Factor-alphaGene Expression ProfilingMacrophagesEndothelial CellsMiddle AgedCoculture TechniquesPlaque AtheroscleroticGene expression profilingLipoproteins LDLEndocrinologyEicosanoidEicosanoid pathwayGene Expression RegulationItalyAtherosclerosiCase-Control StudiesArachidonate 5-lipoxygenasebiology.proteinCancer researchOxidative streTumor necrosis factor alphaFemaleGene expressionmedicine.symptomInflammation MediatorsCardiology and Cardiovascular MedicineCell Adhesion MoleculesAtherosclerosis
researchProduct

Prediction of cardio- and cerebro-vascular events in patients with subclinical carotid atherosclerosis and low HDL-cholesterol.

2007

Low HDL-cholesterol concentrations are associated with increased cardiovascular risk and recent evidences suggest that HDL may aggravate the atherosclerotic process promoting inflammation: HDL are anti-inflammatory in the absence of inflammation but can become proinflammatory in the presence of atherosclerosis. Yet, no data is available on the cardiovascular outcome in subjects with low HDL-cholesterol and early stages of atherosclerosis. Therefore, we included in a prospective 5-year follow-up study 150 subjects with low HDL-cholesterol concentrations and subclinical carotid atherosclerosis, as assessed by carotid colour doppler, evaluating at baseline all the established traditional cardi…

Carotid Artery DiseasesMalemedicine.medical_specialtyPathologyBlood PressureFibrinogenAsymptomaticBody Mass IndexCoronary artery diseaseRisk FactorsInternal medicineDiabetes mellitusMedicineHumansProspective StudiesFamily historySubclinical infectionAgedInflammationbusiness.industryVascular diseasecarotid atherosclerosislow HDL-cholesterolCholesterol HDLMiddle Agedmedicine.diseaseAtherosclerosisSettore MED/11 - Malattie Dell'Apparato Cardiovascolaremedicine.anatomical_structureCerebrovascular CirculationCardiologyFemalemedicine.symptomCardiology and Cardiovascular Medicinebusinessmedicine.drugArteryAterosclerosiFollow-Up StudiesAtherosclerosis
researchProduct

PREDICTION OF CEREBROVASCULAR AND CARDIOVASCULAR EVENTS IN PATIENTS WITH SUBLINICAL CAROTID ATHEROSCLEROSIS: THE ROLE OF C-REACTIVE PROTEIN

2008

Background Several studies have suggested that inflammation and infection may be important for accelerated progression of atherosclerosis, but few data are available on subjects with early stages of atherosclerosis. Methods and Results We included, in a prospective 5-year follow-up study, 150 patients with subclinical carotid atherosclerosis, evaluating at baseline all established traditional cardiovascular risk factors (eg, older age, male sex, obesity, hypertension, diabetes, smoking, family history of coronary artery disease, and dyslipidemia); 2 markers of inflammation, fibrinogen, and high-sensitivity C-reactive protein (CRP); and the seropositivity to Helicobacter pylori, Chlamydia pn…

Carotid Artery DiseasesMalemedicine.medical_specialtyPathologyTime FactorsCoronary DiseaseGeneral Biochemistry Genetics and Molecular BiologyCoronary artery diseaseRisk FactorsInternal medicineDiabetes mellitusmedicineHumansProspective StudiesMyocardial infarctionAgedSubclinical infectionbiologybusiness.industryC-reactive proteinUltrasonography DopplerGeneral MedicineOdds ratioMiddle AgedPrognosismedicine.diseaseC-reactive protein inflammation intimamedia thickness events atherosclerosisSettore MED/11 - Malattie Dell'Apparato CardiovascolareStrokeC-Reactive ProteinCohortbiology.proteinCardiologyFemalebusinessDyslipidemiaFollow-Up Studies
researchProduct

Association of elevated fibrinogen and C-reactive protein levels with carotid lesions in patients with newly diagnosed hypertension or type II diabet…

2006

BACKGROUND: Inflammation may be important for accelerated progression of atherosclerosis in patients with hypertension or diabetes, but few studies included subjects with early stages of atherosclerosis such as those with asymptomatic carotid lesions. METHODS: We studied 100 patients with newly diagnosed hypertension and another 100 patients with newly diagnosed type II diabetes to evaluate in such groups the association of two markers of inflammation, fibrinogen and C-reactive protein (CRP), with carotid atherosclerosis, beyond traditional cardiovascular risk factors (e.g., older age, male gender, obesity, smoking, family history of CAD, dyslipidemia). RESULTS: We found positive correlatio…

Carotid Artery Diseasesmedicine.medical_specialtyInflammationFibrinogenAsymptomaticGastroenterologyInternal medicineDiabetes mellitusmedicineHumansC-reactive protein Hypertension Inflammation Events AtherosclerosisFamily historybiologybusiness.industryC-reactive proteinFibrinogenGeneral Medicinemedicine.diseaseObesityEndocrinologyC-Reactive ProteinCarotid ArteriesDiabetes Mellitus Type 2Hypertensionbiology.proteinmedicine.symptombusinessTunica MediaDyslipidemiamedicine.drugArchives of medical research
researchProduct